Biblio Discovery — Demo Discovery Service

10 results for "Gabriele Spohn"

Showing 1–10 · 3.80 seconds · RSS

  1. Journal Article

    More Human BM-MSC With Similar Subpopulation Composition and Functional Characteristics Can Be Produced With a GMP-Compatible Fabric Filter System Compared to Density Gradient Technique

    Gabriele Spohn; Anne-Sophie Witte; Anja Kretschmer et al.

    Frontiers in Cell and Developmental Biology, Vol. 9 · 2021 · English · DOAJ Scopus

    BackgroundMesenchymal stromal cells (MSCs), multipotent progenitors that can be isolated from a variety of different tissues, are becoming increasingly important as cell therapeutics targeting immunopathologies and tissue regeneration. Current protocols for MSC isolation from bone marrow (BM) rely…

  2. Journal Article Full text

    Variant rs1801157 in the 3’UTR of SDF-1ß Does Not Explain Variability of Healthy-Donor G-CSF Responsiveness

    Miriam Schulz; Darja Karpova; Gabriele Spohn et al.

    PLOS ONE, Vol. 10 No. 3 · 2015 · English · PLOS Scopus

    The genetics responsible for the inter-individually variable G-CSF responsiveness remain elusive. A single nucleotide polymorphism (SNP) in the 3’UTR of CXCL12, rs1801157, was implicated in X4-tropic HiV susceptibility and later, in two small studies, in G-CSR responsiveness in patients and donors…

    Also available at: DOAJ

  3. Journal Article Full text

    Alteration of JNK-1 Signaling in Skeletal Muscle Fails to Affect Glucose Homeostasis and Obesity-Associated Insulin Resistance in Mice

    Martin Pal; Claudia M. Wunderlich; Gabriele Spohn et al.

    PLoS ONE, Vol. 8 No. 1 · 2013 · English · PLOS Scopus

    Obesity and associated metabolic disturbances, such as increased circulating fatty acids cause prolonged low grade activation of inflammatory signaling pathways in liver, skeletal muscle, adipose tissue and even in the CNS. Activation of inflammatory pathways in turn impairs insulin signaling…

    Also available at: DOAJ

  4. Journal Article Full text

    Adaptive Immunity and Pathogenesis of Diabetes: Insights Provided by the α4–Integrin Deficient NOD Mouse

    Salim Oulghazi; Sarah K. Wegner; Gabriele Spohn et al.

    Cells, Vol. 9 No. 12 · 2020 · English · DOAJ Scopus

    Background: The spontaneously diabetic “non-obese diabetic” (NOD) mouse is a faithful model of human type-1 diabetes (T1D). Methods: Given the pivotal role of α4 integrin (CD49d) in other autoimmune diseases, we generated NOD mice with α4-deficient hematopoiesis (NOD.α4-/-) to study the role of α4…

  5. Journal Article

    Small volume bone marrow aspirates with high progenitor cell concentrations maximize cell therapy dose manufacture and substantially reduce donor hemoglobin loss

    Jeremy Epah; Gabriele Spohn; Kathrin Preiß et al.

    BMC Medicine, Vol. 21 No. 1 · 2023 · English · DOAJ Scopus

    Abstract Background Bone marrow (BM) transplantation is a life-saving therapy for hematological diseases, and the BM harbors also highly useful (progenitor) cell types for novel cell therapies manufacture. Yet, the BM collection technique is not standardized. Methods Benchmarking our collection…

  6. Journal Article

    Pooled human bone marrow-derived mesenchymal stromal cells with defined trophic factors cargo promote dermal wound healing in diabetic rats by improved vascularization and dynamic recruitment of M2-like macrophages

    Hélène Willer; Gabriele Spohn; Kimberly Morgenroth et al.

    Frontiers in Immunology, Vol. 13 · 2022 · English · DOAJ Scopus

    Human Mesenchymal Stromal Cells (hMSCs) are a promising source for cell-based therapies. Yet, transition to phase III and IV clinical trials is remarkably slow. To mitigate donor variabilities and to obtain robust and valid clinical data, we aimed first to develop a manufacturing concept balancing…

  7. Journal Article

    Modulating endothelial adhesion and migration impacts stem cell therapies efficacy

    Richard Schäfer; Matthias Schwab; Georg Siegel et al.

    EBioMedicine, Vol. 60 · 2020 · English · DOAJ Scopus

    Background: Limited knowledge of stem cell therapies` mechanisms of action hampers their sustainable implementation into the clinic. Specifically, the interactions of transplanted stem cells with the host vasculature and its implications for their therapeutic efficacy are not elucidated. We tested…

  8. Journal Article

    Cell motility and migration as determinants of stem cell efficacy

    Lusine Danielyan; Matthias Schwab; Georg Siegel et al.

    EBioMedicine, Vol. 60 · 2020 · English · DOAJ Scopus

    Background: Stem cells` (SC) functional heterogeneity and its poorly understood aetiology impedes clinical development of cell-based therapies in regenerative medicine and oncology. Recent studies suggest a strong correlation between the SC migration potential and their therapeutic efficacy in…